[1]
“The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis”, Swiss Med Wkly, vol. 147, no. 4950, p. w14563, Dec. 2017, doi: 10.4414/smw.2017.14563.